Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapy

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

1998 • 2,374 citations

Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C

1998 • 1,318 citations

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients

1999 • 1,234 citations

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

2000 • 917 citations

Human immunodeficiency virus infection modified the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

1997 • 719 citations

Long-Term Histologic Improvement and Loss of Detectable Intrahepatic HCV RNA in Patients with Chronic Hepatitis C and Sustained Response to Interferon-α Therapy

1997 • 571 citations

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C

1997 • 521 citations

Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study.

1993 • 437 citations

INTERFERON ALFA-2b ALONE OR IN COMBINATION WITH RIBAVIRIN FOR THE TREATMENT OF RELAPSE OF CHRONIC HEPATITIS C

1998 • 363 citations

Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study

1994 • 342 citations

The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.

1997 • 316 citations

Heterosexual Co-transmission of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)

1991 • 312 citations

Ribavirin Antagonizes the Effect of Azidothymidine on HIV Replication

1987 • 282 citations

Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study

1994 • 277 citations

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors

1998 • 265 citations

Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion

1999 • 256 citations

Hepatitis C in the HIV (Human Immunodeficiency Virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): The Effect of Coinfection on Survival

1999 • 244 citations

High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV

1995 • 240 citations

Effect of Human Immunodeficiency Virus on Hepatitis C Virus Infection among Injecting Drug Users

1996 • 237 citations

Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections

1993 • 236 citations

Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection

1989 • 235 citations

Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?

1998 • 196 citations

Impact of Treatment with Human Immunodeficiency Virus (HIV) Protease Inhibitors on Hepatitis C Viremia in Patients Coinfected with HIV

1998 • 195 citations

Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.

1999 • 174 citations

The Association between Hepatitis C Virus Genotype and Human Immunodeficiency Virus Disease Progression in a Cohort of Hemophilic Men

1997 • 173 citations

Simultaneous Transmission of Human Immunodeficiency Virus and Hepatitis C Virus from a Needle-Stick Injury

1997 • 170 citations

Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users

1998 • 169 citations

Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus

1996 • 169 citations

Fulminant Hepatic Failure Associated with 2′,3′-Dideoxyinosine (ddI)

1991 • 162 citations

Coinfection of Hepatitis C Virus with Human Immunodeficiency Virus and Progression to AIDS

1995 • 159 citations

Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV.

1996 • 159 citations

Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group.

1997 • 151 citations

Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations Aquitaine Cohort, France, 1996-1998

1999 • 147 citations

Reciprocal Interactions Between Human Immunodeficiency Virus and Hepatitis C Virus Infections

1996 • 132 citations

Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users

1990 • 128 citations

Serum cholesterol, triglycerides, and aggression in the general population

1992 • 124 citations

Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.

1995 • 121 citations

Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients

1998 • 119 citations

Rapidly Evolving Hepatitis C Virus–Related Cirrhosis in a Human Immunodeficiency Virus–Infected Patient Receiving Triple Antiretroviral Therapy

1998 • 116 citations

Management of chronic hepatitis C in HIV-infected patients

1999 • 107 citations

Recombinant Interferon- for Chronic Hepatitis C in Patients Positive for Antibody to Human Immunodeficiency Virus

1992 • 106 citations

Measuring hepatitis C viremia in clinical samples: Can we trust the assays?

1997 • 104 citations

Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patients

2000 • 96 citations

Tritherapy for Human Immunodeficiency Virus Infection Does Not Modify Replication of Hepatitis C Virus in Coinfected Subjects

1998 • 95 citations

Management of hepatitis C

1998 • 95 citations

HEPATITIS C VIRUS-RELATED FIBROSING CHOLESTATIC HEPATITIS AFTER RENAL TRANSPLANTATION

1997 • 94 citations

Antiretroviral drugs for AIDS

1996 • 92 citations

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report

2000 • 92 citations

Response to treatment of chronic hepatitis C with interferon α in patients infected with HIV-1 is associated with higher CD4+ cell count

1998 • 82 citations

Treatment with recombinant α‐interferon of chronic hepatitis C in anti‐HIV‐positive patients

1993 • 82 citations

Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus

1997 • 71 citations

Serious Adverse Events Attributed to Nevirapine Regimens for Postexposure Prophylaxis After HIV Exposures—Worldwide, 1997-2000

2001 • 71 citations

Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs

1996 • 68 citations

Hepatitis C Virus (HCV) Viremia in Human Immunodeficiency VirusSeronegative and -Seropositive Patients with Indeterminate HCV Recombinant Immunoblot Assay

1994 • 66 citations

Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study

1994 • 50 citations

Efficacy and safety of α-interferon treatment for chronic hepatitis C in HIV-infected patients

1995 • 47 citations

Pathobiologic effects of hepatitis C.

1995 • 44 citations

Progression and Clinical Outcome of Infection Due to Human Immunodeficiency Virus

1992 • 42 citations

Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment

2000 • 39 citations

Does HIV-infection influence the response of chronic hepatitis C to interferon treatment? A French multicenter prospective study

2000 • 38 citations

[Seroprevalence of HBV, HCV and HDV hepatitis markers in 500 patients infected with the human immunodeficiency virus].

1997 • 35 citations

Role of endogenous interferon in hepatitis C virus (HGV) infection and in coinfection by HIV and HCV

1996 • 34 citations

Efficacy and safety of combination therapy with interferon-??2b and ribavirin for chronic hepatitis C in HIV-infected patients:

2000 • 23 citations

Treatment of chronic hepatitis C in special groups

1999 • 23 citations

The probability of acquiring primaryToxoplasma infection in HIV-infected patients: Results of an 8-year retrospective study

1998 • 18 citations

Comparison of ribavirin and placebo in CDC group III human immunodeficiency virus infection

1991 • 12 citations

Increased HCV titer and absence of selection of E2 hypervariable region (HVR1) in HCV/HIV coinfection

1994 • 6 citations

Cited By (0)

Loading...